Poster No:
310
Submission Type:
Abstract Submission
Authors:
David Vaughan1,2,3, John Archer2,3, David Abbott1,2, Marty Bryant1, Kristian Bulluss2,3,4, Chris Tailby1,2,3, Graeme Jackson1,2,3
Institutions:
1The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia, 2University of Melbourne, Victoria, Australia, 3Austin Health, Melbourne, Australia, 4St Vincent's Hospital Melbourne, Victoria, Australia
First Author:
David Vaughan
The Florey Institute of Neuroscience and Mental Health|University of Melbourne|Austin Health
Melbourne, Australia|Victoria, Australia|Melbourne, Australia
Co-Author(s):
John Archer
University of Melbourne|Austin Health
Victoria, Australia|Melbourne, Australia
David Abbott, PhD
The Florey Institute of Neuroscience and Mental Health|University of Melbourne
Melbourne, Australia|Victoria, Australia
Marty Bryant
The Florey Institute of Neuroscience and Mental Health
Melbourne, Australia
Kristian Bulluss
University of Melbourne|Austin Health|St Vincent's Hospital Melbourne
Victoria, Australia|Melbourne, Australia|Victoria, Australia
Chris Tailby
The Florey Institute of Neuroscience and Mental Health|University of Melbourne|Austin Health
Melbourne, Australia|Victoria, Australia|Melbourne, Australia
Graeme Jackson
The Florey Institute of Neuroscience and Mental Health|University of Melbourne|Austin Health
Melbourne, Australia|Victoria, Australia|Melbourne, Australia
Introduction:
Stereo-electroencephalography (sEEG) has emerged as a pivotal diagnostic tool for identifying the location of seizure onset in people with drug-resistant focal epilepsy. It involves stereotactic implantation of electrodes into the brain, to record epileptic electrical activity and determine which regions are involved in discharge generation (Isnard, 2018). The goal is to enable safe surgical removal of the critical brain region for effective epilepsy treatment. Additionally, radio-frequency ablation (RFA), a precise treatment to deliver small brain lesions delivered via the implanted sEEG electrodes, can be highly beneficial when targeted accurately (Kerezoudis, 2022).
However, utility of sEEG, and the effectiveness of RFA, both critically depend on the pre-planned location of the intracranial electrodes. Traditionally electrode positions are planned from brain anatomy, seizure symptoms and scalp EEG findings – forms of data which each have limited spatial resolution. To address this issue, we investigated whether presurgical simultaneous EEG and functional MRI (EEG-fMRI), a technique to non-invasively map epileptic discharges, has complementary value for electrode targeting and maximising the benefit of sEEG.
Methods:
We performed EEG-fMRI in people with refractory focal epilepsy during pre-surgical workup for sEEG at Austin Health (2019-2024). Up to 1 hour of continuous in-scanner recording was obtained with the participant resting quietly with eyes closed (Kowalczyk, 2020). Scalp EEG was recorded with 64-channel (BrainVision) or 256-channel (Magstim-EGI) caps. Functional MRI was recorded on a 3T Siemens Prisma or Vida scanner, using multi-band multi-echo echoplanar imaging (cmrr.umn.edu/multiband; 3mm3 voxels, TR 900ms, TE 13.4 / 33.0 / 52.5ms, MB 4, GRAPPA 2, partial Fourier 7/8). Epileptic discharges were identified on the EEG and their timings used to perform fMRI general linear model analysis in SPM12, and event-related Independent Components Analysis (Masterton, 2013).
Curated EEG-fMRI results were provided to the treating team and relevant BOLD activation maps co-registered into the neurosurgical planning workflow. Following the sEEG procedure, medical records were reviewed to determine modifications in the sEEG plan due to the EEG-fMRI data, the sEEG-determined epileptogenic zone, whether RFA was delivered, and the final clinical outcome.
Results:
EEG-fMRI was performed prior to sEEG planning in 11 adults with refractory focal epilepsy (6 male, ages 25-53 years). Structural MRI was normal (55%) or showed extensive structural pathology (45%) such as nodular heterotopia or polymicrogyria. Median seizure frequency was 4.6/week (range 1-14/week) despite mean 3.5 (range 2-4) anti-seizure medications.
EEG-fMRI generated statistically significant interictal activation maps and provided additional information to localize the epileptic focus in 9 of 11 (82%) of cases. The sEEG plan was revised based on the EEG-fMRI result in 8 cases, with a mean of 2.9 electrodes being added/modified out of the overall mean 13.0 electrodes per participant. These modified electrodes identified or provided additional coverage of the final sEEG-determined epileptogenic zone in 88% of cases (7 out of 8).
RFA was performed at the epileptogenic zone in 10 patients. Electrodes positioned because of the EEG-fMRI result were utilized to deliver ablation in 50% of cases. Seizure outcomes were good when RFA was delivered using EEG-fMRI-guided electrodes; 80% of such cases (4 of 5) had transient early seizure freedom at 1 month, with 40% having sustained good outcomes.
Conclusions:
EEG-fMRI can provide non-invasive pre-surgical data to more effectively target sEEG electrodes. In our cohort, this approach increased the likelihood of the epileptogenic zone being sampled. Enhanced placement of intracranial electrodes facilitates delivery of RF ablation as both a diagnostic and therapeutic procedure, especially in difficult-to-localize epilepsy (Figure 1).
Disorders of the Nervous System:
Neurodevelopmental/ Early Life (eg. ADHD, autism) 1
Modeling and Analysis Methods:
Activation (eg. BOLD task-fMRI) 2
Keywords:
ADULTS
Electroencephaolography (EEG)
Epilepsy
FUNCTIONAL MRI
Treatment
Other - Intracranial
1|2Indicates the priority used for review
By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.
I accept
The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information.
Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:
I do not want to participate in the reproducibility challenge.
Please indicate below if your study was a "resting state" or "task-activation” study.
Resting state
Healthy subjects only or patients (note that patient studies may also involve healthy subjects):
Patients
Was this research conducted in the United States?
No
Were any human subjects research approved by the relevant Institutional Review Board or ethics panel?
NOTE: Any human subjects studies without IRB approval will be automatically rejected.
Yes
Were any animal research approved by the relevant IACUC or other animal research panel?
NOTE: Any animal studies without IACUC approval will be automatically rejected.
Not applicable
Please indicate which methods were used in your research:
Functional MRI
EEG/ERP
Other, Please specify
-
stereo-EEG, radiofrequency ablation
For human MRI, what field strength scanner do you use?
3.0T
Which processing packages did you use for your study?
SPM
Free Surfer
Other, Please list
-
fMRIprep, iBrainTools
Provide references using APA citation style.
Isnard et al. (2018). French guidelines on stereoelectroencephalography (SEEG). Neurophysiologie Clinique, 48(1), 5–13.
Kerezoudis et al. (2022). Systematic review and patient-level meta-analysis of radiofrequency ablation for medically refractory epilepsy: Implications for clinical practice and research. Seizure: European Journal of Epilepsy, 102, 113–119.
Kowalczyk et al. (2020). Clinical benefit of presurgical EEG-fMRI in difficult-to-localize focal epilepsy: A single-institution retrospective review. Epilepsia, 61(1), 49–60.
Masterton et al. (2013). Mapping brain activity using event-related independent components analysis: Specific advantages for EEG-fMRI. NeuroImage, 70, 164–174.
No